PCI Pharma Services
PCI is your world leading CDMO, providing integrated end-to-end drug development, manufacturing, and packaging solutions to increase product speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. With 35 sites across Australia, Canada, North America, the UK and Europe and over 8000+ dedicated employees, together, delivering life changing therapies to patients. Leading technology and continued investment enable us to deliver development to commercialization solutions throughout the product lifecycle, collaborating with our clients to improve the lives of patients globally.
PCI Pharma Services Enters Next Phase of Growth With Strategic Investment from Bain Capital, Kohlberg, and Mubadala
PHILADELPHIA – July 14, 2025 – PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and supported with significant reinvestment by Mubadala Investment Company (“Mubadala”). Partners Group...
At BIO Show in Boston, PCI Pharma Services to Provide Updates on New Manufacturing Facility at Nearby Bedford, NH Campus
For leading CDMO, qualification activities for plant’s state-of-the-art sterile fill-finish and lyophilization line are underway, with GMP production commencing summer 2025 6 June 2025 -- Pennsylvania, US -- PCI Pharma Services, a world leading global contract development and manufacturing organization (CDMO), will use the BIO International Convention, June 16-19 in Boston, as a platform to introduce its new...
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges
Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems like prefilled syringes and cartridges, and biologics – including high potent assets for antibody-drug conjugates 1 May 2025, Philadelphia, PA, US – PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma...
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high potent formulations such as ADCs, complementing existing global sterile fill-finish and advanced drug delivery operations 24 April 2025 -- Pennsylvania, US -- PCI Pharma Services – a leading global contract development and manufacturing organization...
PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug
Leading CDMO performing sterile drug manufacturing, lyophilization, testing/QA and packaging operations for mission-critical drug. 19 November 2024 – Philadelphia, PA, US – PCI Pharma Services (“PCI”) a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies – is collaborating with theranostics specialist ChiRhoClin, Inc. to avoid the potential shortage of...
PCI Pharma Services Wins Supply Chain Excellence Award for Groundbreaking Digital Platform to Manage Clinical Trials and Commercial Lifespans
Leading CDMO’s pci | bridgeTM enhances supply chain visibility and reduces time spent on manual activities such as forecasting, inventory management, reporting, supplier management and document sharing. 30 October 2024 – Philadelphia, US – PCI Pharma Services, (“PCI”)a leading global contract development and manufacturing organization (CDMO) focused on biopharma’s most complex therapies, has earned a Supply...
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
Highlights include investment in Philadelphia biotech facility, acquisition of a new pharma device assembly and packaging facility near Dublin, Ireland, and a new Center of Excellence for advanced drug delivery and drug-device combination product assembly and packaging in Rockford, Illinois. 24 September 2024 – Philadelphia, PA – PCI Pharma Services, (“PCI”)a leading global contract development...
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
PCI is the first CDMO to undergo ICMRA’s inspection pilot program. 21 August 2024 - Philadelphia, US – PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus. In doing so, PCI becomes the...
During BIO Show, PCI Pharma Services to Highlight Sterile Fill-Finish Robotics Technologies at Nearby San Diego Manufacturing Plant
Robotics-assisted systems support sterile filling of vials, prefilled syringes and cartridges during clinical trials, substantially limiting drug product loss while reducing timeline 20 May 2024 -- Pennsylvania, US -- PCI Pharma Services, a leading global contract development and manufacturing organisation (CDMO), will highlight the recently incorporated robotics technology for sterile fill-finish operations at its San...
PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilisation Line as Part of $100m New Facility Expansion
Construction and validation activities at leading CDMO’s Bedford, New Hampshire, US, campus will conclude later this year, with GMP production commencing early 2025 2 May 2023 -- Pennsylvania, US -- PCI Pharma Services, a world leading global contract development and manufacturing organisation (CDMO), has begun installation of key equipment for its newest sterile fill-finish facility...
